Weedstocks Newswire Feed
VANCOUVER, British Columbia, June 26, 2019 /CNW/ -- MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) ("MYM" or "The Company") is pleased to announce it has engaged Kirsty Morrison as Territory Manager for European Operations. Ms. Morrison will be located in London, England and will lead the European CBD Sales and Distribution team.
Ms. Morrison has established relationships in the emerging UK CBD market to use as the launching point for European operations. The company is exploring a number of projects in Europe with the goal of becoming a global distributor of bulk CBD isolate and unique products.
"In keeping with our Strategic Plan, we're delighted to welcome Kirsty to the MYM family and look forward to expanding our CBD distribution efforts into Europe," said Howard Steinberg, CEO of MYM. "Europe is one of the fastest growing markets for CBD products with a projected market approaching $2 billion by 2023. MYM aims to be at the forefront of this movement by positioning the company to be a key player in the importation and distribution of CBD products."
Ms. Morrison has ten years of experience as Operations Manager in the hospitality industry in the UK. She served as a Sales Manager for a global events company, coordinating events around the world for high net worth clients and luxury brands. Most recently, Kirsty was an Operational Consultant within the cannabis industry in Canada where she gained valuable experience in the sales, distribution, and marketing of CBD products.
About MYM Nutraceuticals Inc. MYM Nutraceuticals Inc. is an innovative company focused on the global growth of Cannabis and hemp. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC: MYMMF) (FRA: 0MY) (DEU: 0MY) (MUN: 0MY) (STU: 0MY).
VANCOUVER, June 25, 2019 /CNW/ - Village Farms International, Inc. (the "Company" or "Village Farms") (TSX: VFF) (NASDAQ: VFF) announced today that all of the director nominees listed in the management information circular dated May 21, 2019 were elected as directors of the Company at the annual meeting of shareholders held earlier today (the "Meeting"). The results of the vote for each nominee director are set out below:
Proxy Votes For
Proxy % For
Proxy Votes Withheld
Chemesis International Inc. Receives Approval from the State of Michigan to Initiate Construction of its Hemp Processing Facility
TORONTO, June 25, 2019 /CNW/ - OPSEU President Warren (Smokey) Thomas says he's not the least bit surprised that complaints to the province's ombudsman have jumped by 30 per cent since the Ford government came to power.
"When you govern with cuts and chaos, people get hurt," said Thomas. "People are in pain. People need help. And people have learned the hard way that they just can't count on any support from the clapping seals in the Conservative caucus. It's no wonder they've been flooding the ombudsman's office with complaints."
In his annual report, Ontario Ombudsman Paul Dube said his overburdened office received nearly 2,500 complaints about the Ontario Cannabis Store and all the confusion and shortages that have marred legalization.
"No shocker there," said Thomas. "To pay off his insiders and rich backers, Ford blew up the responsible plan for public cannabis sales that our union helped create. If he'd stuck with that plan, we'd now have dozens upon dozens of safe and trustworthy publicly run cannabis outlets in communities across the province.
"Instead, we've still only got a handful of profit-driven businesses. And the criminal market is having a heyday."
LONDON and TORONTO, June 25, 2019 /CNW/ - Shivom Ventures Limited ("Shivom"), a biotechnology data and analysis company optimising the way DNA is shared, secured and analysed through blockchain and AI technology, and TruTrace Technologies Inc. (CSE: TTT; OTC: TTTSF) ("TruTrace" or the "Company"), which has developed the first integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, announced that the two companies have signed a letter of intent ("LOI") to establish a strategic working relationship. The companies will explore a partnership to utilize both Shivom and TruTrace's blockchain solutions in order to disrupt the global medicinal and recreational cannabis markets.
Through the LOI, Shivom is entering into the booming cannabis market, which is projected to hit US$40 billion by 2024 – nearly triple the US$14.9 billion estimated to be spent this year, according to ArcView Market Research and cannabis industry analysis firm BDS Analytics.
"Shivom is excited to enter the cannabis market via a strategic partnership with TruTrace, which has developed the first integrated blockchain platform to register and track IP in the cannabis industry," said Shivom CEO, Henry Ines. "As the industry is still in its early stages in terms of understanding and uncovering all of the medicinal benefits associated with the use of CBD, Shivom is keen to work with leading organizations in the space such as TruTrace to further uncover additional therapeutic benefits based on one's genomic profile and unique personal health information. Shivom anticipates significant opportunities to collaborate with TruTrace and its partners to provide clinical research opportunities, medical insights and personalized healthcare products to consumers and patients within the global cannabis ecosystem."
"Shivom has developed some very interesting technology that combines genomics, cryptography and AI, and we are excited to begin collaborating with them," said TruTrace CEO, Robert Galarza. "We plan to explore development and integration opportunities to advance clinical research, and bring greater transparency, insights and viability to the legal medical and recreational cannabis industry."
For more information about Shivom please visit here To read more about our affiliation with Living DNA please visit here To read more about our affiliation with Vitl please visit here To read more about our affiliation with Chronomics please visit here
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CSE: CL) (OTCQX: CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today provided an update on its Illinois operations following Governor JB Pritzker’s signing into law of the legalization of adult-use cannabis in Illinois beginning on January 1, 2020.
“The legalization of adult-use cannabis and the recent expansion of the state’s medical-use program are expected to dramatically increase the consumer base in Illinois and result in annual sales of $2 billion to $4 billion as the market matures,” said Cresco Labs CEO & Co-Founder Charlie Bachtell. “We are making excellent progress on our plans to serve the expanded consumer base, maintain our market leading position in Illinois, and capitalize on the significant growth opportunities available to Cresco. On January 1, 2020, we will have the ability to open five additional retail dispensaries for the sale of adult-use cannabis, bringing our total number of dispensaries in the state to 10, the maximum any one company is permitted to have. We expect to have the additional five dispensaries open by the launch of the adult use marketplace. We will also continue to operate three cultivation facilities, also the maximum that any one company is permitted to have. We are currently expanding our cultivation facility in Lincoln to 170,000 square feet, which is expected to be completed in Q4 and will provide us with a larger source for high-quality cannabis to brands serve the increase in demand expected in 2020.”
The market share leader in Illinois, Cresco Labs currently distributes its suite of wholesale brands to every retail dispensary in Illinois:
“We are also very proud to be taking on a leadership position in helping Illinois meet the social equity provisions of the adult-use cannabis legislation,” said Mr. Bachtell. “As the first company in the cannabis industry to introduce a comprehensive national social equity & education initiative (SEED), Cresco is committed to helping a broader segment of our population pursue business ownership and employment opportunities in the cannabis industry. We are very encouraged by the initial response and participation we have seen with our expungement events, educational programs, and community impact business incubator, and we are making steady progress on our goal to provide 20,000 individuals across the country with the opportunity to seek employment in the cannabis industry by 2022.”
About Cresco Labs
With 10 anticipated retail licenses in Illinois, including pending acquisitions, MedMen will be a leading cannabis retailer in the state
Company anticipates creating hundreds of local jobs following its expansion
LOS ANGELES--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF) applauds Illinois Governor J.B. Pritzker’s enactment of adult use cannabis legalization.
Governor Pritzker’s bold action sets a new standard for legalization efforts at the state level. The legislation calls for sweeping criminal justice reforms, with over 770,000 cannabis-related cases eligible for expungement under the act. The new law will automatically expunge convictions for possession of up to 30 grams. It also contains a social equity program, which aims to benefit those directly affected by the War on Drugs. Social equity applicants will be awarded additional points in the scoring system through which licenses are awarded and will have resources for start-up costs made available to them. The program’s 3R (Restore, Reinvest, and Renew) strategy encourages community groups to develop programs to benefit disadvantaged communities.
VANCOUVER, June 25, 2019 /CNW/ - Ovation Science Inc. (CSE: OVAT) ("Ovation" or the "Company"), a product development company with a patented skin delivery technology and twenty-plus years of skincare research and development, is pleased to announce that its product under license in the USA, remains the #1 topical cannabis product sold in Nevada dispensaries.
According to Headset data, a cannabis analytics company that provides key business intelligence to the cannabis industry, Ovation Science's transdermal CBD (cannabidiol) formulation under license again is ranked the #1 selling topical in Nevada in June by number of units sold according to their latest update. This follows a previous announcement that it ranked #1 in April (and continued to be #1 through-out May). (Source: https://www.headset.io)
Ovation's patented skin delivery technology, Invisicare®, is the backbone of all products developed by Ovation Science. It provides exceptional topical and transdermal delivery of CBD and THC to and through the skin; greater than other products on the market according to the Company's research studies. With five products already being successfully sold in Nevada dispensaries, the Company looks forward to future growth to other states by its licensee as well as the launch of their own product lines in July.
"The continued #1 ranking of our product in Nevada will be a catalyst to expansion into other states by our licensee," said Terry Howlett, President of Ovation. "This will add immediate royalty revenue and shareholder value as our products will have the opportunity to be offered in significantly more dispensaries than before." He added, "We also have interest from potential licensees outside of the USA including Canada and Europe and these opportunities would give Ovation's products the opportunity for global expansion."